BioSpace News Archive

Rheos Medicines today announced the peer-reviewed publication of preclinical data supporting MALT1 inhibition as a novel therapeutic strategy to treat autoimmune and inflammatory diseases.

Moderna, Inc. today announced that it will host its in-person Science and Technology Day for analysts and investors at 9:00 a.m. ET on Tuesday, May 17 in Boston, MA.

NeoGenomics, Inc. announced the appointment of Vishal Sikri as President and Chief Commercial Officer of Inivata and the departure of former President of Inivata Dr. Clive Morris.

Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, reported financial results for the first quarter ended March 31, 2022 and provided a business update.

VectivBio Holding AG announced that Luca Santarelli, M.D., Ph.D., Founder and Chief Executive Officer of VectivBio, will participate in a fireside chat at the Bank of America 2022 Healthcare Conference in Las Vegas, NV.

Mind Medicine today announced that it will host its earnings call on Monday, May 16, 2022 , at 8:30 a.m. EDT to discuss its financial results for the quarter ended March 31, 2022 and provide a business update.

Biohaven Pharmaceutical Holding Company Ltd. plans to hold its upcoming first quarter 2022 earnings call and webcast, reporting financial results for the quarter ended March 31, 2022, and provide a review of recent accomplishments and anticipated upcoming milestones, on Wednesday, May 11, 2022 at 8:30 a.m. ET.

NEXGEL, Inc. today announced that it will report its financial and operating results for the first quarter of 2022 after the market closes on May 12, 2022.

Oncology Pharma Inc. is pleased to execute its next phase with Connect2Trials, Inc. Originally, the Company engaged with Ribera Solutions, Inc. Connect2 on its patient engagement platform for clinical trials.

Biovica International today announces that the company’s blood test DiviTumTKa will be included in one oral presentation and two abstracts/posters, at the world’s largest cancer congress, ASCO Annual Meeting, June 3-7, 2022, in Chicago, USA.